Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen
- 1 January 2006
- journal article
- research article
- Published by Informa UK Limited in Scandinavian Journal of Urology and Nephrology
- Vol. 40 (2), 155-160
- https://doi.org/10.1080/00365590500497960
Abstract
Objective. To determine if there is a relationship between acute urinary retention (AUR), the prostate-specific antigen (PSA) level and chronic inflammation of the prostate. We therefore studied patients with benign prostatic obstruction (BPO) with (n=64) or without (n=168) acute urinary retention (AUR) who underwent transurethral resection of the prostate (TURP) in a retrospective case control study. Material and methods. Between 2001 and 2004, a total of 232 patients underwent TURP due to BPO with or without AUR. The mean values of age, prostate volume, weight of resected prostate and PSA level and the histopathologic results of patients with and without AUR were compared. χ2 analysis was used to examine the relationship between prostatic inflammation and AUR. The contribution of each variable to AUR was assessed by means of multiple linear regression. Results. A total of 64 patients (28%) were operated on for AUR due to BPO. There were no statistical differences between patients with or without AUR with respect to the mean values of PSA, percent free PSA, prostate size or weight of the resected prostate tissue. Elevated PSA values (≥4.0 ng/ml) were detected in 64% and 38% of the patients in the AUR and non-AUR groups, respectively (p=0.01). Histopathological re-evaluation demonstrated that chronic prostatic inflammation was present in 56% and 37% of the specimens in the AUR and non-AUR groups, respectively (p=0.014). In the AUR group, the mean PSA level was significantly higher in patients with than without prostatic inflammation (7.75±5.26 vs 5.07±3.21 ng/ml; p=0.022). The odds ratio of AUR for patients with chronic prostatic inflammation and elevated PSA was determined as 4.14 (95% CI 1.65–10.41). Multiple linear regression revealed that prostatic inflammation made a significant contribution to AUR. Conclusions. Chronic prostatic inflammation may be histopathological evidence of both elevated PSA level and AUR; hence it may play a role in the pathophysiology of AUR.Keywords
This publication has 23 references indexed in Scilit:
- Randomised, Placebo Controlled, Double Blind Study of Alfuzosin SR in Patients Undergoing Trial without Catheter Following Acute Urinary RetentionEuropean Urology, 2002
- Asymptomatic inflammation and/or infection in benign prostatic hyperplasiaBJU International, 1999
- Fortnightly review: Acute urinary retention in men: an age old problemBMJ, 1999
- Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasiaUrology, 1999
- PROSTATIC INFARCTION/INFECTION IN ACUTE URINARY RETENTION SECONDARY TO BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1998
- Prostate-specific Antigen (PSA), PSA Density and Age-adjusted PSA Reference Values in Screening for Prostate Cancer: A Study of a Randomly Selected Population of 2,400 MenScandinavian Journal of Urology and Nephrology, 1998
- Natural History of Prostatism: Risk Factors for Acute Urinary RetentionJournal of Urology, 1997
- Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen LevelsJournal of Urology, 1995
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987